We haven't heard any more regarding the graphic in your post which states that Fuji will be starting P2 GvHD trials in late 2020.
I thought we may have had some feedback by now on ethics approval, trial approvals etc. for this trial. I have a theory now, that they are waiting on the MSB GvHD FDA approval (or not), before committing to a trial procedure. Any issues found by the FDA could be addressed in a tailored trial which addresses any questions raised.
It would be great to go head to head with an identical trial against the MSB technology. I was hoping this would be achieved with the COVID trial, but it would seem we limited ourselves geographically on this front.
- Forums
- ASX - By Stock
- The Cymerus Process
We haven't heard any more regarding the graphic in your post...
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
|
|||||
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $35.20M |
Open | High | Low | Value | Volume |
20.0¢ | 20.0¢ | 19.5¢ | $1.705K | 8.654K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 12792 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 32500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 10018 | 0.195 |
4 | 126276 | 0.190 |
3 | 15055 | 0.180 |
2 | 5997 | 0.175 |
1 | 50000 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 46000 | 1 |
0.210 | 60000 | 1 |
0.220 | 1875 | 1 |
0.240 | 10000 | 1 |
0.255 | 187726 | 1 |
Last trade - 10.02am 30/08/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online